Skip to content

Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak

Ayurveda Self-Management for Flu Like Symptoms in People Self-Isolated for 7 Days During the Coronavirus Disease 2019 (COVID-19) Outbreak

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04345549
Enrollment
18
Registered
2020-04-14
Start date
2020-02-26
Completion date
2020-03-30
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flu Like Illness, Flu Like Symptom

Brief summary

From the end of January 2020, Coronavirus disease 2019 began to spread in United Kingdom (UK). During the same time, seasonal flu continued to circulate across the UK. With similar course of management at early stages, flu like symptoms were self-isolated to prevent the spread and further complications of infection. Present study aimed to evaluate the effect of self-managed Ayurveda on flu like symptoms in people who self-isolated at home for 7-days in March 2020 during the Covid-19 outbreak in UK.

Interventions

OTHERIndividualised Ayurveda

Saline warm water gargle, Steam, Paracetamol for body temperature and plenty fluid and rest, Food and herbs recommendation as per individual Ayurveda constitution, Using Ginger/ lemon/ turmeric/ honey recommended as per individual, Yoga breathing

Sponsors

Aarogyam UK
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal obstruction, sore throat) and at least one constitutional symptom other than fever (e.g. fatigue, headache, myalgias) of less than 48-hour duration * Willing to consent and follow up

Exclusion criteria

* Pregnant/lactating * Participants with chronic pulmonary diseases or critical condition or already developed severe respiratory distress * Clinically malignancies, systemic infection, other medical or psychiatric condition which places the subject at unacceptable risk to participate in the study - Known hypersensitivity to any ayurveda herbal substances

Design outcomes

Primary

MeasureTime frameDescription
Time to achieve afebrileFrom Baseline to 3rd and 7th-days of interventionTime to bring down a fever (oral temperature \< 37.2˚C)

Secondary

MeasureTime frameDescription
Severity of influenza symptom scoreTwice daily from Day 1 to Day 7Symptoms diary card completed twice daily from Day 0 to Day 7

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026